The Ministry of Health and Consumer Affairs started it on Monday. Vaccination campaign against Respiratory Syncytial Virus (RSV)Main cause of respiratory tract infection, such as bronchiolitis or pneumonia.
Starting last Thursday, September 14, the SAS has started calling parents and guardians of children under six months of age. The doses acquired for the 2023-2024 campaign amount to approximately 63,600, with a total budget of 13.8 million euros. But, what is this vaccine? Who needs to be vaccinated? and when?
Junta of Andalusia The Endavac website provides comprehensive information about bronchiolitis and the medicines that prevent it.
What is bronchiolitis, frequency, symptoms and who usually suffers from it?
Bronchiolitis is an inflammation of the thin branches of the bronchi, causing blockage and difficulty breathing in infants.
This is quite normal, especially in the first year of life., in a way that most infants eventually experience it, although with varying degrees of impact. it is known One in 50 boys and girls is hospitalized for bronchiolitis at some point in the first year of life.
Most bronchiolitis is mild and similar to a cold that clears up within a few days. Other times, when the child has had a runny nose and cough for 3-4 days. It begins with difficulty breathing and “wheezing” in the chest., You may also have a mild fever, loss of appetite, vomiting with mucus, or difficulty eating.
Bronchiolitis can be a serious disease in premature babies, infants younger than 3 months, and children with heart, respiratory, muscle, or immune system problems (changes in defenses); It is more common in young children (under 2 years), especially those under 6 months of age.
Last year, 301 minors had to be hospitalized at the same time in Andalusia due to infection with the virus., with the largest peak occurring in November. And, overall, according to SAS records, RSV caused the need for hospitalization in 2,581 children under one year of age in 2022.
Which compound will be supplied
Andalusia will for the first time administer a monoclonal antibody against RSV, called nirsevimab, with the business name of Beaufortswill be administered muscle Like most vaccines and administration A dose for this season Autumn-Winter 2023-2024. The current technical sheet can be viewed at this link.
In this way, the Autonomous Community continues to focus on health prevention, With one of the most advanced vaccination programs in the national region.
This measure is added to the annual flu vaccination In the population of children from 6 months to 5 years (59 months), which started in Andalusia during the 2022-2023 campaign, with the aim of protecting children as much as possible from the most frequent respiratory pathologies that result in hospitalization Offers greater chances of being recruited.
With this vaccination, infection with this virus is effectively and safely prevented, A respiratory condition that occurs especially during autumn and winter,
Who will get the vaccine?
These doses will be given to all children born from October 1, 2023 to March 31, 2024. (The day the campaign ends), Also all babies born between April 1 and September 30, 2023As the board explained in detail in a statement.
Additionally, they will be administered Children under one year of age with a history of preterm birth less than 35 weeksas well as Other infants with very high-risk chronic pathology up to 24 months,
The Ministry of Health and Consumer Affairs has recommended All parents with children under six months of age must accept the invitation for RSV vaccination,
when will they get the vaccine
group 1: Less than 6 months.
- Subgroup 1A: Who were born between April 1, 2023 and September 30, 2023. They will receive it from September 25, 2023.
- Subgroup 1B: Who were born between October 1, 2023 and March 31, 2024. They will receive it after birth, before discharge from the maternity hospital.
Group 2: Children under 1 year of age with a history of preterm birth less than 35 weeks of gestation. They will receive it from September 25, 2023. If they belong to Group 1B, they will follow the instructions of Group 1B.
Group 3: Children under 2 years of age with high-risk conditions. They will receive it from September 25, 2023. Dates will be specified later (the official date of arrival of doses in Andalusia is pending). If they belong to Group 1B, they will follow the instructions of Group 1B.
Where will they get the vaccine
group 1: Less than 6 months.
- Subgroup 1A: Who were born between April 1, 2023 and September 30, 2023. They will receive it in primary care.
- Subgroup 1B: Born between October 1, 2023 and March 31, 2024. They will receive this in the hospital, before discharge from the maternity ward.
Group 2: Children under 1 year of age with a history of preterm birth less than 35 weeks of gestation. They will get it in primary care. If they belong to Group 1B, they will follow the instructions of Group 1B.
Group 3: Children under 2 years of age with high-risk conditions. They will receive you at the hospital. If they belong to Group 1B, they will follow the instructions of Group 1B. Boys and girls with Down syndrome can get it in primary care.
Estimated doses by province
In Andalusia, the estimated dose for each is Almería, 7,435; Cadiz, 8,691, Cordoba, 5,417; Grenada, 7,943; Huelva, 4,141; Jane, 4,814; Málaga, 11,819, and Seville, 13,341.
In the first year of childhood flu vaccine administration, more than 45% of the target population has been reached. On the other hand, the Directorate General of Public Health and Pharmaceutical Regulation has included RSV in the acute respiratory infection sentinel surveillance protocols in both primary and hospital care, thus joining the joint COVID19/flu surveillance strategy established for 2020-2021. Was done. Season.